Biotechnology

Filter

Current filters:

None

Popular Filters

1900 to 1924 of 2299 results

Sunshine Act data collection delayed to January 2013, says USA's CMS

08-05-2012

In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Life sciences M&A activity heats Up in April, says Burrill & Co

07-05-2012

April proved to be a big month for M&A activity in the life sciences as companies announced more than…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

US NIH debuts collaborative program with Pharma to spur therapeutic development

07-05-2012

The US National Institutes of Health last week unveiled a collaborative program that will match researchers…

AstraZenecaBiotechnologyEli LillyNorth AmericaPfizerPharmaceuticalResearch

GAO report finds that USA's FDA has met most PDUFA performance goals

04-05-2012

A report dated March 30 but only released earlier this week by the US Government Accountability Office…

BiotechnologyNorth AmericaPharmaceuticalRegulation

New biologics and biosimilars approval guidelines in Mexico

04-05-2012

In Mexico, new guidelines are now in effect for the market authorization of biologics and biosimilars,…

BiotechnologyGenericsRegulationSouth America

Genzyme gains FDA and EMA approval for Irish production plant

03-05-2012

US biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) said yesterday that…

BiotechnologyEuropeGenzymeLumizymeMyozymeRegulationSanofi

Unmet needs in orphan diseases therapy offer opportunity for Big Pharma; report

03-05-2012

Patients suffering from orphan diseases can look forward to a wider range of drug options in the future,…

BiotechnologyMarkets & MarketingPharmaceuticalRare diseasesResearch

Patient perspectives influencing drug development

02-05-2012

Support is growing for increased collaboration between pharmaceutical companies and patients in research…

BiotechnologyPharmaceuticalRegulationResearch

Biogen Idec 1st-qtr sales up 7% but fail to match expectations

02-05-2012

US biotech company Biogen Idec (Nasdaq: BIIB) post first-quarter 2012 sales of $1.29 billion, a rise…

Biogen IdecBiotechnologyFinancial

New business model to relaunch the BioPharma industry, from ADL

01-05-2012

Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

Actelion's macitentan meets primary endpoint in pivotal Phase III PAH study

01-05-2012

Europe's largest biotech company, Actelion (SIX: ATLN), says that initial analysis indicates that the…

ActelionBiotechnologymacitentanResearchRespiratory and Pulmonary

Biopharmaceuticals "no longer a growth market" in Germany

30-04-2012

After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

FDA stalls Amgen's Xgeva sBLA for prevention of bone metastases

30-04-2012

USA-based Amgen (Nasdaq: AMGN) revealed on Friday that the US Food and Drug Administration has issued…

AmgenBiotechnologyNorth AmericaOncologyRegulationXgeva

BIO asks US House Committee on Ways and Means to extend critical tax provisions; backs Obama Bioeconomy Blueprint

29-04-2012

US trade group the Biotechnology Industry Organization (BIO) has submitted a statement for the record…

BiotechnologyFinancialNorth AmericaPolitics

Drugmakers looking to shorten time to early clinical development, says Tufts CSDD

29-04-2012

Pharmaceutical companies looking to increase the efficiency and productivity of their R&D pipelines are…

BiotechnologyNorth AmericaPharmaceuticalResearch

Sanofi's strong 1st-qtr driven by Genzyme

27-04-2012

French drug major Sanofi (Euronext: SAN) posted a strong set of first-quarter 2012 financial results…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

Epizyme earns upfront $90 million in deal with Celgene; latter posts 17% sales hike

27-04-2012

Privately-held Epizyme and Celgene International Sarl, a subsidiary of USA-based Celgene Corp (Nasdaq:…

BiotechnologyCelgeneEpizymeFinancialLicensingOncologyPharmaceutical

Amylin operating loss leaps to over $30 million

27-04-2012

US biotech firm Amylin Pharmaceuticals (Nasdaq AMLN): reported financial results for the quarter ended…

AmylinBiotechnologyFinancialMergers & Acquisitions

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million

26-04-2012

Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Positive Ph III data for Biogen Idec's oral MS drug candidate BG-12

25-04-2012

US biotech firm Biogen Idec (Nasdaq: BIIB) says that detailed positive data from CONFIRM, the second…

Biogen IdecBiotechnologydimethyl fumarateNeurologicalResearch

Amgen beats forecasts as EPS leaps more than 20%

25-04-2012

USA-based Amgen (Nasdaq: AMGN), the world's biggest independent biotech company, posted strong first-quarter…

AmgenBiotechnologyFinancial

GSK takeover target Human Genome sees 4th-qtr loss narrow

25-04-2012

Human Genome Sciences (Nasdaq: HGSI), the subject of a $2.59 billion hostile takeover bid from the UK's…

BenlystaBiotechnologyFinancialHuman Genome Sciences

1900 to 1924 of 2299 results

Back to top